Chelsea Counsel Company’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$897K Sell
1,315
-15
-1% -$10.4K 0.4% 46
2025
Q4
$758K Hold
1,330
0.33% 54
2025
Q3
$810K Hold
1,330
0.36% 51
2025
Q2
$665K Sell
1,330
-56
-4% -$27.5K 0.33% 54
2025
Q1
$710K Sell
1,386
-60
-4% -$28.6K 0.39% 47
2024
Q4
$679K Hold
1,446
0.35% 53
2024
Q3
$764K Hold
1,446
0.38% 53
2024
Q2
$630K Sell
1,446
-100
-6% -$45.7K 0.31% 61
2024
Q1
$740K Hold
1,546
0.42% 43
2023
Q4
$724K Hold
1,546
0.38% 53
2023
Q3
$681K Hold
1,546
0.35% 61
2023
Q2
$705K Buy
1,546
+100
+7% +$45.4K 0.35% 59
2023
Q1
$668K Sell
1,446
-21
-1% -$9.74K 0.32% 66
2022
Q4
$800K Hold
1,467
0.4% 60
2022
Q3
$690K Sell
1,467
-19
-1% -$9.05K 0.43% 58
2022
Q2
$711K Sell
1,486
-10
-0.7% -$4.59K 0.37% 61
2022
Q1
$669K Sell
1,496
-13
-0.9% -$5.37K 0.29% 63
2021
Q4
$584K Hold
1,509
0.25% 67
2021
Q3
$543K Hold
1,509
0.25% 63
2021
Q2
$548K Hold
1,509
0.25% 61
2021
Q1
$488K Sell
1,509
-110
-7% -$33.2K 0.24% 63
2020
Q4
$493K Hold
1,619
0.25% 62
2020
Q3
$511K Hold
1,619
0.3% 56
2020
Q2
$498K Sell
1,619
-50
-3% -$16.4K 0.31% 55
2020
Q1
$505K Sell
1,669
-50
-3% -$17.4K 0.4% 49
2019
Q4
$591K Sell
1,719
-73
-4% -$25.7K 0.36% 49
2019
Q3
$672K Hold
1,792
0.4% 49
2019
Q2
$579K Hold
1,792
0.31% 56
2019
Q1
$483K Sell
1,792
-120
-6% -$32.7K 0.26% 60
2018
Q4
$468K Hold
1,912
0.28% 61
2018
Q3
$607K Hold
1,912
0.32% 58
2018
Q2
$588K Hold
1,912
0.35% 58
2018
Q1
$668K Sell
1,912
-1,590
-45% -$533K 0.43% 45
2017
Q4
$1.07M Sell
3,502
-3,600
-51% -$1.08M 0.57% 42
2017
Q3
$2.04M Sell
7,102
-330
-4% -$88.8K 1.02% 30
2017
Q2
$1.91M Buy
7,432
+130
+2% +$32.5K 0.99% 31
2017
Q1
$1.74M Sell
7,302
-400
-5% -$95K 0.89% 32
2016
Q4
$1.79M Sell
7,702
-2,030
-21% -$472K 0.94% 32
2016
Q3
$2.08M Buy
9,732
+70
+0.7% +$15.2K 1.07% 31
2016
Q2
$2.15M Sell
9,662
-352
-4% -$74.1K 0.97% 33
2016
Q1
$1.98M Buy
10,014
+54
+0.5% +$10.2K 0.64% 46
2015
Q4
$1.88M Sell
9,960
-625
-6% -$115K 0.57% 47
2015
Q3
$1.76M Buy
10,585
+200
+2% +$33.5K 0.42% 50
2015
Q2
$1.65M Sell
10,385
-150
-1% -$24K 0.37% 50
2015
Q1
$1.7M Sell
10,535
-123
-1% -$19.7K 0.37% 50
2014
Q4
$1.57M Sell
10,658
-100
-0.9% -$13.7K 0.32% 51
2014
Q3
$1.42M Buy
10,758
+1,432
+15% +$181K 0.28% 55
2014
Q2
$1.12M Sell
9,326
-70
-0.7% -$8.46K 0.22% 58
2014
Q1
$1.16M Hold
9,396
0.24% 58
2013
Q4
$1.08M Sell
9,396
-3,322
-26% -$356K 0.25% 53
2013
Q3
$1.21M Buy
12,718
+35
+0.3% +$3.23K 0.25% 55
2013
Q2
$1.05M Buy
+12,683
New +$987K 0.28% 52

Other funds holding NOC

Chelsea Counsel Company's NOC Position: Q1 2026 in Review

Chelsea Counsel Company reduced its Northrop Grumman (NOC) stake by 1.1% in Q1 2026, selling an estimated $10.4K and leaving 1,315 shares worth $897K. The position accounts for 0.4% of the portfolio, ranked #46.

Chelsea Counsel Company first reported a position in NOC in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.15M in Q2 2016. 1,878 funds tracked by Wall St. Rank hold NOC as of Q1 2026.

  • Chelsea Counsel Company held 1,315 shares of Northrop Grumman worth $897K as of Q1 2026.
  • Chelsea Counsel Company sold 15 Northrop Grumman shares in Q1 2026, an estimated $10.4K.
  • Northrop Grumman made up 0.4% of Chelsea Counsel Company's portfolio in Q1 2026, its #46 holding.
  • Chelsea Counsel Company first reported a position in Northrop Grumman in Q2 2013 and has held it in 52 quarters since.
  • Chelsea Counsel Company's Northrop Grumman position peaked at $2.15M in Q2 2016.
  • 1,878 funds tracked by Wall St. Rank held Northrop Grumman as of Q1 2026.

Based on Chelsea Counsel Company's 13F filing for Q1 2026, filed 24 Apr 2026.